Gilead suspends access to experimental coronavirus drug
Biotechnology company Gilead Sciences is halting emergency access to its experimental coronavirus drug, citing "overwhelming demand." The coronavirus outbreak has caused such a surge in requests for the drug, called remdesivir, that they have "flooded an emergency treatment access system…